Dichloromethane → HCID 178463344, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([NH:11][C@H:12]2[CH2:17][CH2:16][C@H:15]([C:18]([N:20]3[CH2:25][CH2:24][N:23](C(OC(C)(C)C)=O)[CH2:22][C@@H:21]3[C:33]3[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=3)=[O:19])[CH2:14][CH2:13]2)(=[O:10])=[O:9])=[CH:4][C:3]=1[NH:39][CH2:40][CH3:41].C(O)(C(F)(F)F)=O.C(Cl)Cl.C(Cl)Cl.[OH-].[Na+]>O>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([NH:11][C@H:12]2[CH2:17][CH2:16][C@H:15]([C:18]([N:20]3[CH2:25][CH2:24][NH:23][CH2:22][C@@H:21]3[C:33]3[CH:34]=[CH:35][CH:36]=[CH:37][CH:38]=3)=[O:19])[CH2:14][CH2:13]2)(=[O:9])=[O:10])=[CH:4][C:3]=1[NH:39][CH2:40][CH3:41]Participants
6
Procedure
(S)-tert-Butyl 4-(trans-4-(4-chloro-3-(ethylamino)phenylsulfonamido)cyclo-hexanecarbonyl)-3-phenylpiperazine-1-carboxylate (Example 1, 77 mg, 0.127 mmol) was stirred in 20% v/v TFA/DCM overnight. The reaction was dilutee with DCM and water and the pH was adjusted to 13 with 1N NaOH. The layers were separated, and the organic layer was concentrated and chromatographed on reverse phase Phenomenex Gemini Axia C18 30×100 mm column using a gradient of 15-100% AcCN in water containing 5 mM ammonium hydroxide. The product was lyophilized to yield the title compound (31.5 mg, 0.62 mmol). MS MH+ 505.4.
Workup
- customThe layers were separated
- concentrationthe organic layer was concentrated
- customchromatographed on reverse phase Phenomenex Gemini Axia C18 30×100 mm column
Sources & evidence
- ORD record
- ord-ae3d8e396e9c4ebe999c37e02be6e859
- Source dataset
- uspto-grants-2013_03
- Patent number
- US08394858B2
Reaction notes
Loading…